A detailed history of Allianz Se transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Allianz Se holds 2,490 shares of EW stock, worth $180,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,490
Previous 2,490 -0.0%
Holding current value
$180,898
Previous $180 Million 7.91%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025

SELL
$67.95 - $76.19 $140,656 - $157,713
-2,070 Reduced 45.39%
2,490 $180 Million
Q4 2024

Feb 12, 2025

BUY
$64.54 - $75.92 $294,302 - $346,195
4,560 New
4,560 $339 Million
Q3 2024

May 12, 2025

BUY
$59.7 - $93.78 $322,977 - $507,349
5,410 Added 386.43%
6,810 $449 Million
Q2 2024

May 12, 2025

SELL
$84.3 - $94.31 $195,576 - $218,799
-2,320 Reduced 62.37%
1,400 $129 Million
Q1 2024

May 12, 2025

BUY
$72.54 - $95.56 $89,224 - $117,538
1,230 Added 49.4%
3,720 $355 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Allianz Se Portfolio

Follow Allianz Se and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Se, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Se with notifications on news.